Comparison of Prasugrel at the Time of PCI or as Pretreatment at the Time of Diagnosis in Patients With Non-ST Elevation Myocardial Infarction - ACCOAST

Description:

Current guidelines recommend pretreatment with clopidogrel in patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing an invasive approach. In the TRITON-TIMI 38 trial comparing prasugrel to clopidogrel in patients presenting with ACS, prasugrel significantly reduced the incidence of ischemic endpoints. In that trial, prasugrel was administered following coronary angiography. The current trial sought to study if pretreatment with prasugrel in all patients would...